Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide alone versus semaglutide plus metformin XR for weight loss and gut health in adults with obesity
RBR-6pjdr2rRecruiting
- Sponsor
- Universidade Estadual de Campinas
- Start
- Feb 2026
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in obesity comparing Semaglutide plus diet with Semaglutide plus metformin XR plus diet (2 arms). Started Feb 2026; status: recruiting.
02
Drugs
semaglutidemetformin
03
Conditions
obesity
Beyond the preview
Go deeper on RBR-6pjdr2r.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6pjdr2r.